Study Summary
This trial tests if a medical device helps reduce blood loss during surgery.
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 24 - 36 hours
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
1 Treatment Group
Blood Loss and Saline Infusion
1 of 1
Experimental Treatment
20 Total Participants · 1 Treatment Group
Primary Treatment: Blood Loss and Saline Infusion · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 20 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are new participants still eligible to enroll in this trial?
"Affirmative. Clinicaltrials.gov records suggest that this experiment is currently recruiting participants, having first been published on February 13th 2023 and lastly modified on the same day. The study requires at least twenty volunteers to be found from a single site." - Anonymous Online Contributor
What is the total recruitment of participants for this experiment?
"Affirmative. The information hosted on clinicaltrials.gov indicates that this medical research is currently seeking volunteers, with the original post date being February 13th 2023 and the last update occurring on the same day. Altogether, twenty patients are needed for this exploration of one site." - Anonymous Online Contributor